tiprankstipranks
Kansas City Life Insurance Company (KCLI)
OTHER OTC:KCLI
US Market

Kansas City Life Insurance Company (KCLI) AI Stock Analysis

15 Followers

Top Page

KCLI

Kansas City Life Insurance Company

(OTC:KCLI)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
$32.00
▼(-3.76% Downside)
Action:ReiteratedDate:03/12/26
The score is held down primarily by worsening earnings in 2024–2025 and consistently negative cash flow, which weaken overall financial performance. Technical indicators are broadly neutral with only mild negative momentum, and valuation support is limited because the negative P/E reflects losses despite a modest dividend yield.
Positive Factors
Conservative Balance Sheet
No reported debt materially reduces financial risk and gives the company durable capacity to absorb underwriting volatility or investment stress. Over months, low leverage supports regulatory capital, preserves strategic optionality for reinsurance or opportunistic asset purchases, and limits insolvency risk.
Negative Factors
Persistent Negative Cash Flow
Sustained operating and free cash outflows weaken financial flexibility and force reliance on investment realizations or capital actions. Over a multi-month horizon this limits ability to support new sales, pay claims from operating receipts, invest in technology/distribution, or withstand prolonged adverse mortality or market shocks.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
No reported debt materially reduces financial risk and gives the company durable capacity to absorb underwriting volatility or investment stress. Over months, low leverage supports regulatory capital, preserves strategic optionality for reinsurance or opportunistic asset purchases, and limits insolvency risk.
Read all positive factors

Kansas City Life Insurance Company (KCLI) vs. SPDR S&P 500 ETF (SPY)

Kansas City Life Insurance Company Business Overview & Revenue Model

Company Description
Kansas City Life Insurance Company provides insurance products and services in 49 states and the District of Columbia. It offers a portfolio of individual insurance, annuity, and group life and health insurance; and traditional life insurance, imm...
How the Company Makes Money
KCLI primarily makes money through (1) insurance underwriting income and (2) investment income on invested assets supporting policy liabilities and capital. Underwriting-related revenue comes from policyholder premiums collected on in-force polici...

Kansas City Life Insurance Company Financial Statement Overview

Summary
Financials are pressured by deteriorating profitability (losses in 2024 that widened in 2025 with negative operating earnings and ~-4% net margin) and persistently negative operating/free cash flow (2021–2025, with a sharp outflow in 2025). The main offset is a conservative balance sheet with no reported debt and sizable equity, which reduces financial risk but does not fully compensate for weak earnings and cash generation.
Income Statement
38
Negative
Balance Sheet
74
Positive
Cash Flow
27
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue485.45M490.74M494.97M475.95M494.65M
Gross Profit485.45M126.33M120.51M103.98M100.83M
EBITDA-28.02M-2.80M74.56M-14.16M20.89M
Net Income-20.76M-4.96M54.92M-16.22M10.70M
Balance Sheet
Total Assets4.89B5.02B4.64B4.97B5.43B
Cash, Cash Equivalents and Short-Term Investments8.43M274.35M9.70M2.27B3.17B
Total Debt0.000.000.000.000.00
Total Liabilities4.23B4.44B4.44B4.08B4.20B
Stockholders Equity665.58M581.45M609.36M491.69M830.43M
Cash Flow
Free Cash Flow-130.81M-59.67M-51.45M-54.87M-46.95M
Operating Cash Flow-130.55M-58.37M-50.54M-54.33M-46.32M
Investing Cash Flow45.03M-13.01M-2.60M-89.17M-7.86M
Financing Cash Flow85.85M69.78M55.07M145.85M52.40M

Kansas City Life Insurance Company Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price33.25
Price Trends
50DMA
32.53
Negative
100DMA
32.27
Negative
200DMA
32.11
Positive
Market Momentum
MACD
-0.11
Positive
RSI
47.44
Neutral
STOCH
39.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KCLI, the sentiment is Neutral. The current price of 33.25 is above the 20-day moving average (MA) of 32.28, above the 50-day MA of 32.53, and above the 200-day MA of 32.11, indicating a neutral trend. The MACD of -0.11 indicates Positive momentum. The RSI at 47.44 is Neutral, neither overbought nor oversold. The STOCH value of 39.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for KCLI.

Kansas City Life Insurance Company Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$44.67M25.364.89%0.74%11.99%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
58
Neutral
$3.31B16.562.54%1.41%150.35%
54
Neutral
$3.44B8.557.20%27.71%
52
Neutral
$260.05M16.596.43%-0.55%-51.14%
47
Neutral
$309.86M-14.97-5.65%1.75%-3.32%-162.81%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
KCLI
Kansas City Life Insurance Company
32.00
1.74
5.75%
AAME
Atlantic American
2.19
0.63
40.38%
CIA
Citizens
5.17
1.30
33.59%
GNW
Genworth Financial
8.54
2.39
38.86%
BHF
Brighthouse Financial
60.15
12.32
25.76%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 12, 2026